DECEMBER, 2013 Gene-Related Patent Applications Posted - Full application: http://appft1.uspto.gov/netahtml/PTO/srchnum.html
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY
Appl Number Title Assignee Date Issued Country
20130337511 Method for Producing Pyrroloquinoline Quinone Using a Bacterium of the Genus Methylobacterium or Hyphomicrobium AJINOMOTO CO., INC. 19-Dec-13 Japan
20130337540 Novel Class of Therapeutic Protein Based Molecules Ansun Biopharma, Inc. 19-Dec-13 United States
20130323720 COMBINATION OF BIOMARKERS FOR THE DETECTION AND EVALUATION OF HEPATITIS FIBROSIS BIO RAD INNOVATIONS 5-Dec-13 France
20130330824 ENABLING THE USE OF LONG dsRNA FOR GENE TARGETING IN MAMMALIAN AND OTHER SELECTED ANIMAL CELLS BOSTON BIOMEDICAL, INC. 12-Dec-13 United States
20130323838 TRIGGERED RNAi CALIFORNIA INSTITUTE OF TECHNOLOGY 5-Dec-13 United States
20130337446 METHOD OF PREPARING A STANDARD DIAGNOSTIC GENE TRANSCRIPT PATTERN DIAGENIC AS 19-Dec-13 Norway
20130330771 ANTIBODY PRODUCTION Erasmus University Medical Center 12-Dec-13 Netherlands
20130323780 PROMOTERS AND TERMINATORS FOR USE IN EUKARYOTIC CELLS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 5-Dec-13 United States
20130344482 GENE FOR PREDICTING THE PROGNOSIS FOR EARLY-STAGE BREAST CANCER, AND A METHOD FOR PREDICTING THE PROGNOSIS FOR EARLY-STAGE BREAST CANCER BY USING THE SAME Gencurix Inc 26-Dec-13 Korea
20130323759 SPINAL MUSCULAR ATROPHY DIAGNOSTIC METHODS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 5-Dec-13 France
20130323836 5'-END DERIVATIVES Isis Pharmaceuticals, Inc. 5-Dec-13 United States
20130323785 METHOD FOR PRODUCING HUMAN EPIDERMAL GROWTH FACTOR IN LARGE VOLUME FROM YEAST KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY 5-Dec-13 Korea
20130344553 Designer Calvin-Cycle-Channeled and Hydrogenotrophic Production of Butanol and Related Higher Alcohols Lee; James Weifu 26-Dec-13 United States
20130337458 Human trophoblast stem cells and and methods of therapeutic screening Lee; Jau-Nan 19-Dec-13 Taiwan
20130337533 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt Niehrs; Christof 19-Dec-13 Germany
20130330781 Endoglucanases NOVOZYMES A/S 12-Dec-13 Denmark
20130344479 METHOD FOR EARLY DIAGNOSIS OF CARCINOMAS OF THE ANOGENITAL TRACT Oncgnostics GmbH 26-Dec-13 Germany
20130323791 RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN MICE Regeneron Pharmaceuticals, Inc. 5-Dec-13 United States
20130344483 DETECTION OF MUTATIONS IN A GENE ENCODING IKB KINASE-COMPLEX-ASSOCIATED PROTEIN TO DIAGNOSE FAMILIAL DYSAUTONOMIA Rubin; Berish Y. 26-Dec-13 United States
20130330790 Renewable Chemicals and Fuels from Oleaginous Yeast SOLAZYME, INC. 12-Dec-13 United States
20130323735 MEANS AND METHODS FOR INVESTIGATING NUCLEIC ACID SEQUENCES Stichting Sanquin Bloedvoorziening 5-Dec-13 Netherlands
COMBINATORIAL CHEMISTRY TECHNOLOGY
Appl Number Title Assignee Date Issued Country
20130324438 METAGENE EXPRESSION SIGNATURE FOR PROGNOSIS OF BREAST CANCER PATIENTS Berx; Geert 5-Dec-13 Belgium
20130324427 ASSESSMENT AND REDUCTION OF RISK OF GRAFT-VERSUS-HOST DISEASE BIOSYSTEMIX LTD. 5-Dec-13 United States
20130345080 Diagnosis, Prognosis and Identification of Potential Therapeutic Targets of Multiple Myeloma Based on Gene Expression Profiling Board of Trustees of the University of Arkansas 26-Dec-13 United States
20130338025 USE OF GENE EXPRESSION PROFILING TO PREDICT SURVIVAL IN CANCER PATIENT Board of Trustees of the University of Arkansas 19-Dec-13 United States
20130338026 Prognostic Marker for Endometrial Carcinoma Carter; Scott L. 19-Dec-13 United States
20130324436 PROCEDURE FOR NUCLEIC ACID-BASED DIAGNOSTIC DETERMINATION OF BACTERIAL GERM COUNTS AND KIT FOR THIS PURPOSE DIAGON KFT 5-Dec-13 Hungary
20130338043 Efficient, Expansive, User-Defined DNA Mutagenesis Firnberg; Elad 19-Dec-13 United States
20130338012 GENETIC RISK FACTORS OF SICK SINUS SYNDROME ILLUMINA INC. 19-Dec-13 United States
20130338034 METABOLIC DISEASES-RELATED ODORANT RECEPTOR GENES AND USE THEREOF Industry-Academic Cooperation Foundation 19-Dec-13 Korea
20130345074 Biomarker and method for evaluating risk for Parkinson's disease LEE-CHEN; Guey-Jen 26-Dec-13 Taiwan
20130331281 MOLECULAR MARKERS FOR PROGNOSTICALLY PREDICTING PROSTATE CANCER, METHOD AND KIT THEREOF National Health Research Institutes 12-Dec-13 Taiwan
20130331300 Selection and Enrichment of Proteins Using In Vitro Compartmentalization NEW ENGLAND BIOLABS, INC. 12-Dec-13 United States
20130345064 CONTINUOUS DIRECTED EVOLUTION President and Fellows of Harvard College 26-Dec-13 United States
20130345091 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC MYELOID LEUKEMIA AND ACUTE LYMPHOBLASTIC LEUKEMIA St. Jude Children's Research Hospital 26-Dec-13 United States
20130338018 PRIMERS, SEQUENCES AND RECOMBINANT PROBES FOR IDENTIFICATION OF MYCOBACTERIUM SPECIES UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC. 19-Dec-13 United States
20130338035 MHC Genes and Risk of Graft Versus Host Disease UNIVERSITY OF NEWCASTLE UPON TYNE 19-Dec-13 United Kingdom
20130345086 CD4+ T-CELL GENE SIGNATURE FOR RHEUMATOID ARTHRITIS (RA) UNIVERSITY OF NEWCASTLE UPON TYNE 26-Dec-13 United Kingdom
20130338016 Method For Integrated Pathology Diagnosis And Digital Biomarker Pattern Analysis Vala Sciences, Inc. 19-Dec-13 United States
DATA PROCESSING
Appl Number Title Assignee Date Issued Country
20130332081 VARIANT ANNOTATION, ANALYSIS AND SELECTION TOOL OMICIA INC 12-Dec-13 United States
20130332083 Gene Marker Sets And Methods For Classification Of Cancer Patients Van Laar; Ryan 12-Dec-13 United States
DRUG
Appl Number Title Assignee Date Issued Country
20130344101 B7-1-PE40KDEL EXOTOXIN FUSION GENE-BASED DNA VACCINE AND THE USE THEREOF AFFILIATED HOSPITAL OF ACADEMY OF MILITARY MEDICAL SCIENCES, PLA 26-Dec-13 China P Rep.
20130345295 TARGETED ONCOLYTIC ADENOVIRUS FOR TREATMENT OF HUMAN TUMORS, CONSTRCUTION METHOD AND APPLICATION THEREOF Beijing Bio-Targeting Therapeutics Technology Inc. 26-Dec-13 China P Rep.
20130324588 RNA Interference Mediated Inhibition of Catenin (Cadherin-Associated Protein), Beta 1 (CTNNB1) Gene Expression Using Short Interfering Nucleic Acid (siNA) Brown; Duncan 5-Dec-13 United States
20130338089 METHODS AND COMPOUNDS FOR MODULATING THE SECRETION OR EXPRESSION OF ADHESION PROTEINS OR ANGIOPOIETINS OF CELLS CHAN; Pui-Kwong 19-Dec-13 United States
20130345294 Light-Switchable Gene Expression System EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY 26-Dec-13 China P Rep.
20130323235 Soluble heavy-chain only antibodies ERASMUS UNIVERSITY MEDICAL CENTER 5-Dec-13 Netherlands
20130331442 Combination Therapy for Cancer FINVECTOR VISION THERAPIES LTD 12-Dec-13 United Kingdom
20130336947 PEPTIDES AND USES FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA 19-Dec-13 United States
20130324503 Method of identifying and treating a person having a predisposition to or afflicted with Parkinson disease Health Research Inc. 5-Dec-13 United States
20130330362 HUMANIZED ANTI-EGFR ANTIBODY L4-H3 AND CODING GENE THEREOF HEFEI TAIRUI BIOTECHNOLOGY CO., LTD 12-Dec-13 China P Rep.
20130323206 GENE DELIVERY SYSTEM HAVING ENHANCED TUMOR-SPECIFIC EXPRESSION, AND RECOMBINANT GENE EXPRESSION REGULATING SEQUENCE Industry-University Cooperation Foundation Hanyang University 5-Dec-13 Korea
20130344033 RECOMBINANT PROBIOTIC BACTERIA FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) AND IRRITABLE BOWEL SYNDROME (IBS) INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 26-Dec-13 France
20130324479 METHODS FOR INDUCING EPITHELIAL CANCER CELL SENESCENCE Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center 5-Dec-13 United States
20130345291 METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA INTEGRATED DNA TECHNOLOGIES, INC. 26-Dec-13 United States
20130345144 Use of ID4 for Diagnosis and Treatment of Cancer JOHN WAYNE CANCER INSTITUTE 26-Dec-13 United States
20130344040 PROCESS FOR THE PREPARATION OF A COMPOSITION OF GENETICALLY MODIFIED HEMATOPOIETIC PROGENITOR CELLS JOHNSON & JOHNSON RESEARCH PTY. LIMITED 26-Dec-13 Australia
20130336880 METHODS FOR IN VIVO IDENTIFICATION OF CANCER INITIATING CELLS BY MULTIMODALITY REPORTER GENE IMAGING LEE; Yi-Jang 19-Dec-13 Taiwan
20130338215 COMPOSITION AND METHOD FOR OLIGONUCLEOTIDE DELIVERY Lieberman; Judy 19-Dec-13 United States
20130338211 NOVEL REPRESSOR ON IFN-LAMBDA PROMOTER AND SIRNA AGAINST ZEB1 AND BLIMP-1 TO INCREASE IFN-LAMBDA GENE ACTIVITY MEDICAL DIAGNOSTIC LABORATORIES, LLC 19-Dec-13 United States
20130324533 METHOD OF DETECTING RESISTANCE TO CANCER THERAPY NATIONAL UNIVERSITY OF SINGAPORE 5-Dec-13 Singapore
20130331437 METHODS FOR MODULATING THE EXPRESSION AND AGGREGATION OF CAG-EXPANDED GENE PRODUCT IN CELLS AND METHODS FOR IDENTIFYING AGENTS USEFUL FOR DOING THE SAME National Yang Ming University 12-Dec-13 Taiwan
20130344106 Methods and Compositions for Improving Immune Response by a Nutraceutical Antioxidant NEL; ANDRE E. 26-Dec-13 United States
20130323298 Amphoteric Liposome Formulation Novosom AG 5-Dec-13 United States
20130344039 TH1-ASSOCIATED MICRORNAS AND THEIR USE FOR TUMOR IMMUNOTHERAPY Okada; Hideho 26-Dec-13 United States
20130345187 METHOD FOR PRE-SCREENING AND CORRELATION OF UNDERLYING SCARB1 GENE VARIATION TO INFERTILITY IN WOMEN AND THERAPEUTIC USE OF PROGESTATIONAL AND OTHER MEDICATIONS IN TREATMENT Rodriguez Oquendo; Annabelle 26-Dec-13 United States
20130323231 TREATMENT AND PROGNOSIS OF SOLID TUMOUR CANCERS ROYAL COLLEGE OF SURGEONS IN IRELAND 5-Dec-13 Ireland
20130330341 SINGLE NUCLEOTIDE POLYMORPHISMS IN THE PROMOTER OF VEGFA GENE AND THEIR USE AS PREDICTIVE MARKERS FOR ANTI-VEGF TREATMENTS SANOFI 12-Dec-13 France
20130323232 METHODS FOR THE IDENTIFICATION AND TREATMENT OF PATIENTS SENSITIVE TO ANTI IGF-1R INHBITION THERAPY Sathyanarayanan; Sriram 5-Dec-13 United States
20130336979 DIAGNOSTIC AND TREATMENT OF CHRONIC HEART FAILURE Smih; Fatima 19-Dec-13 France
20130331430 Compositions And Methods For Inhibiting Expression Of The PCSK9 Gene Tan; Pamela 12-Dec-13 United States
20130344004 MATRIX METALLOPROTEASE TARGETING NUCLEIC ACIDS The General Hospital Corporation 26-Dec-13 United States
20130331432 METABOLIC GENE, ENZYME, AND FLUX TARGETS FOR CANCER THERAPY The General Hospital Corporation d/b/a Massachusetts General Hospital 12-Dec-13 United States
20130323313 Mucus Penetrating Gene Carriers THE JOHNS HOPKINS UNIVERSITY 5-Dec-13 United States
20130345268 Methods and Compositions for the Treatment of RAS Associated Disorders The Trustees of Dartmouth College 26-Dec-13 United States
20130331438 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF THE UNIVERSITY OF WESTERN AUSTRALIA 12-Dec-13 Australia
20130330403 Diagnosis And Treatment Of Cancers With MicroRNA Located In Or Near Cancer-Associated Chromosomal Features Thomas Jefferson University 12-Dec-13 United States
20130330367 COMPOSITIONS WITH ENHANCED IMMUNOGENICITY AND/OR REDUCED REACTOGENICITY Vaxinnate Corporation 12-Dec-13 United States
20130344095 METHOD OF USING CD1D OVER-EXPRESSION IN HUMAN DENDRITIC CELLS TO ENHANCE CD8+ T CELL-BASED AND INVARIANT NATURAL KILLER T CELL-BASED ANTITUMOR IMMUNITY Wang; Shu 26-Dec-13 Singapore
20130331459 A-Ring Modified 19-Nor-Vitamin D Analogs and Their Uses Wisconsin Alumni Research Foundation 12-Dec-13 United States
MULTICELLULAR LIVING ORGANISMS
Appl Number Title Assignee Date Issued Country
20130340112 Plant genome sequence and uses thereof Boukharov; Andrey A 19-Dec-13 United States
20130347135 ANIMAL MODEL FOR PARKINSON'S DISEASE Chan; David C. 26-Dec-13 United States
20130347145 METHOD FOR ACCUMULATING PROTEIN IN PLANT CELLS HONDA MOTOR CO., LTD. 26-Dec-13 Japan
20130326724 Annotated plant genes Kovalic; David K. 5-Dec-13 United States
20130333071 Plant Genome Sequence and Uses Thereof MONSANTO TECHNOLOGY LLC 12-Dec-13 United States
20130347143 METHOD FOR PRODUCING LILIES CONTAINING DELPHINIDIN IN THE PETALS THEREOF NIIGATA PREFECTURE 26-Dec-13 Japan
20130347133 Methods For Identifying Compounds That Modulate Untranslated Region-Dependent Gene Expression And Methods Of Using Same PTC Therapeutics, Inc. 26-Dec-13 United States
20130340104 Humanized IL-7 Rodents Regeneron Pharmaceuticals, Inc. 19-Dec-13 United States
20130333057 Humanized Non-Human Animals with Restricted Immunoglobulin Heavy Chain Loci Regeneron Pharmaceuticals, Inc. 12-Dec-13 United States
20130326736 NEMATODE RESISTANT CROPS THE CURATORS OF THE UNIVERSITY OF MISSOURI 5-Dec-13 United States
20130340113 USE OF THE COFFEE HOMEOBOX GENE CAHB12 TO PRODUCE TRANSGENIC PLANTS WITH GREATER TOLARANCE TO WATER SCARCITY AND SALT STRESS UNIVERSIDADE FEDERAL DO RIO DE JANEIRO 19-Dec-13 Brazil
20130340116 SWITCHGRASS PROMOTER AND USES THEREOF UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 19-Dec-13 United States
OPTICS
Appl Number Title Assignee Date Issued Country
20130337444 NANO46 Genes and Methods to Predict Breast Cancer Outcome NanoString Technologies, Inc. 19-Dec-13 United States
PLANT PROTECTING AND REGULATING COMPOSITIONS
Appl Number Title Assignee Date Issued Country
20130324408 AAD-12 EVENT 416, RELATED TRANSGENIC SOYBEAN LINES, AND EVENT-SPECIFIC IDENTIFICATION THEREOF DOW AGROSCIENCES LLC 5-Dec-13 United States
20130338007 HERBICIDE RESISTANCE GENE AND USE THEREOF HANGZHOU LEADGENE LIMITED INC. 19-Dec-13 China P Rep.
20130338006 STACKED HERBICIDE TOLERANCE EVENT 8291.45.36.2, RELATED TRANSGENIC SOYBEAN LINES, AND DETECTION THEREOF MS TECHNOLOGIES, LLC 19-Dec-13 United States
Bookmark and Share

Login



alta vista babel fish
To traslate this page, click a flag!
flag flag flag flag flag flag flag flag

Advertisements

Miracle Ear
What will your miracle sound like?
Miracle Ear Hearing Aids
Dayal Resources, Inc.
Translations from German to English, including patents, research papers, legalese and materials for publication. Dayal Resources, Inc. is your dependable resource. Please contact wdayal@dayalresources.com
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.